Tian Qiuyue, Chen Shuohua, Zhang Jie, Li Cancan, Wu Shouling, Wang Yanxiu, Wang Youxin
Beijing Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, 10 YouanmenXitoutiao, Beijing, 100069 China.
Department of Cardiology, Kailuan General Hospital, North China University of Science and Technology, 57 Xinhua East Road, Tangshan, 063000 China.
EPMA J. 2023 May 20;14(2):185-199. doi: 10.1007/s13167-023-00322-8. eCollection 2023 Jun.
Whether cardiovascular health (CVH) metrics impact longevity with and without cardiovascular diseases (CVDs) has not been well established. This study aimed to investigate the association between CVH metrics and life expectancy in participants free of CVD events. We hypothesized that ideal CVH status was associated with increased life expectancy and assessed the effect of CVH status as a prevention target of longevity in the framework of predictive, preventive, and personalized medicine (PPPM/3PM).
A total of 92,795 participants in the Kailuan study were examined and thereafter followed up until 2020. We considered three transitions (from non-CVD events to incident CVD events, from non-CVD events to mortality, and from CVD events to mortality). The multistate lifetable method was applied to estimate the life expectancy.
During a median follow-up of 13 years, 12,541 (13.51%) deaths occurred. Compared with poor CVH, ideal CVH attenuated the risk of incident CVD events and mortality without CVD events by approximately 58% and 27%, respectively. Women with ideal CVH at age 35 had a 5.00 (3.23-6.77) year longer life expectancy free of CVD events than did women with poor CVH metrics. Among men, ideal CVH was associated with a 6.74 (5.55-7.93) year longer life expectancy free of CVD events.
An ideal CVH status is associated with a lower risk of premature mortality and a longer life expectancy, either in the general population or in CVD patients, which are cost-effective ways for personalized medicine of potential CVD patients. Our findings suggest that the promotion of a higher CVH score or ideal CVH status would result in reduced burdens of CVD events and extended disease-free life expectancy, which offered an accurate prediction for primary care following the concept of PPPM/3PM.
The online version contains supplementary material available at 10.1007/s13167-023-00322-8.
心血管健康(CVH)指标对有或无心血管疾病(CVD)人群寿命的影响尚未明确。本研究旨在调查无CVD事件参与者中CVH指标与预期寿命之间的关联。我们假设理想的CVH状态与预期寿命延长相关,并在预测、预防和个性化医学(PPPM/3PM)框架下评估CVH状态作为长寿预防目标的效果。
开滦研究中共有92795名参与者接受检查,之后随访至2020年。我们考虑了三种转变(从无CVD事件到发生CVD事件、从无CVD事件到死亡、从CVD事件到死亡)。采用多状态生命表法估计预期寿命。
在中位随访13年期间,发生了12541例(13.51%)死亡。与不良CVH相比,理想CVH分别使发生CVD事件的风险和无CVD事件时的死亡风险降低了约58%和27%。35岁时具有理想CVH的女性无CVD事件的预期寿命比CVH指标不良的女性长5.00(3.23 - 6.77)年。在男性中,理想CVH与无CVD事件的预期寿命延长6.74(5.55 - 7.93)年相关。
理想的CVH状态与较低的过早死亡风险和较长的预期寿命相关,无论是在普通人群还是CVD患者中,这是潜在CVD患者个性化医疗的经济有效方式。我们的研究结果表明,提高CVH评分或达到理想CVH状态将减轻CVD事件负担并延长无病预期寿命,这为遵循PPPM/3PM概念的初级保健提供了准确预测。
在线版本包含可在10.1007/s13167 - 023 - 00322 - 8获取的补充材料。